Dark Streaming/Mobile Old Site Home Products Help Contact Us Your Account System Status
Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS
02:01:09 EST Sun 08 Feb 2026
Enter Symbol
or Name
USA
CA



Bioharvest Sciences Inc
Symbol BHSC
Shares Issued 478,688,168
Close 2023-12-15 C$ 0.21
Market Cap C$ 100,524,515
Recent Sedar+ Documents

Bioharvest Sciences grants option to buy 300,000 shares

2023-12-15 16:38 ET - News Release

Subject: Release/News Attached Word Document File: '\\swfile\EmailIn\20231215 133210 Attachment 121523 BHSC NR 300,000 Stock options Final.docx' CSE:BHSC - FSE:8MV - OTC: CNVCF OFSE:8MV NR: 121523-1 BIOHARVEST SCIENCES INC. ANNOUNCES GRANT OF STOCK OPTIONS VANCOUVER, BC, December 15, 2023 - BioHarvest Sciences Inc. ("BioHarvest" or the "Company") (CSE: BHSC) (OTCQB: CNVCF) (FSE: 8MV) announces that it has granted a total of 300,000 stock options to a consultant. The stock options granted are exercisable to purchase a common share of the Company at a price of CA$ 0.21 per share for a term of 10 years and will vest quarterly over a 3-year period. About BioHarvest Sciences Inc. BioHarvest Sciences Inc. (CSE: BHSC) is a fast-growing Biotech firm listed on the Canadian Securities Exchange. BioHarvest has developed a patented bio-cell growth platform technology capable of growing the active and beneficial ingredients in fruit and plants, at an industrial scale, without the need to grow the plant itself. BioHarvest is currently focused on leveraging its botanical synthesis technology to develop the next generation of science-based and clinically proven therapeutic solutions, within two major business verticals - nutraceutical health and wellness products such as dietary supplements, and development of plant cell-based Active Pharmaceutical Ingredients (API's) that focus on specific medical indications. Visit: www.bioharvest.com. BioHarvest Sciences Inc. Ilan Sobel, Chief Executive Officer For further information, please contact: Dave Ryan, VP Investor Relations & Director Phone: 1 (604) 622-1186 Email: dave@bioharvest.com Forward-Looking Statements Information set forth in this news release includes forward-looking statements that are based on management's current estimates, beliefs, intentions, and expectations, and are subject to a number of risks and uncertainties that could cause actual results to differ materially from those described in the forward-looking statements. There is no assurance that we will achieve our objective of being a leading supplier of Cannabis. Delays and cost overruns may result in delays achieving our objectives. Projected sales of Cannabis will require the company to obtain production and / or export licensing which cannot be assured. All forward-looking statements are inherently uncertain and actual results may be affected by a number of material factors beyond our control. Readers should not place undue reliance on forward-looking statements. BHSC does not intend to update forward-looking statement disclosures other than through our regular management discussion and analysis disclosures. Neither the Canadian Securities Exchange nor its Regulation Services Provider accept responsibility for the adequacy or accuracy of this release.

© 2026 Canjex Publishing Ltd. All rights reserved.